Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis

被引:0
|
作者
Tieghi, T. [1 ]
Marocco, R. [1 ]
Belvisi, V. [1 ]
Del Borgo, C. [1 ]
Savinelli, S. [1 ]
Lichtner, M. [1 ]
Mastroianni, C. M. [1 ,2 ]
机构
[1] Univ La Sapienza, Fdn Eleonora Lorillard Spencer Cenci, Dept Publ Hlth & Infect Dis, I-04100 Latina, Italy
[2] Univ La Sapienza, SM Goretti Hosp, Infect Dis Unit, I-04100 Latina, Italy
关键词
Sustained Virologic Response; Triple Therapy; Telaprevir; Boceprevir; Legionellosis;
D O I
10.1007/s15010-013-0543-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:225 / 226
页数:2
相关论文
共 50 条
  • [1] Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis
    T. Tieghi
    R. Marocco
    V. Belvisi
    C. Del Borgo
    S. Savinelli
    M. Lichtner
    C. M. Mastroianni
    Infection, 2014, 42 : 225 - 226
  • [2] Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C
    Kohjima, Motoyuki
    Kurokawa, Miho
    Enjoji, Munechika
    Yoshimoto, Tsuyoshi
    Nakamura, Tsukasa
    Ohashi, Tomoko
    Fukuizumi, Kunitaka
    Harada, Naohiko
    Murata, Yusuke
    Matsunaga, Kazuhisa
    Kato, Masaki
    Kotoh, Kazuhiro
    Nakamuta, Makoto
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (05) : 1781 - 1787
  • [3] Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C
    Al-Bawardy, Badr
    Kim, W. Ray
    Poterucha, John J.
    Gross, John B.
    Charlton, Michael R.
    Larson, Joseph J.
    Colby, Colin L.
    Canterbury, Kathy
    Warner, Jennifer
    Therneau, Terry M.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (05) : 595 - 601
  • [4] Postmarketing surveillance of telaprevir-based triple therapy for chronic hepatitis C in Japan
    Shiraishi, Muneshige
    Umebayashi, Itsuro
    Matsuda, Hiroaki
    Sawamura, Keisuke
    Okada, Aiko
    Karino, Masako
    Nogami, Yoshihide
    HEPATOLOGY RESEARCH, 2015, 45 (13) : 1267 - 1275
  • [5] Improvement of Liver Stiffness Measured by ARFI During Telaprevir-Based Triple Therapy for Chronic Hepatitis C
    Kanata, Ryo
    Goto, Takashi
    Miura, Kouichi
    Ohshima, Shigetoshi
    Shibuya, Tomomi
    Sato, Wataru
    Kamada, Kentaro
    Chiba, Mitsuru
    Sakai, Toshitaka
    Minami, Shinichiro
    Sugimoto, Yuko
    Fujiwara, Junichi
    Ishioka, Mitsuaki
    Ohnishi, Hirohide
    GASTROENTEROLOGY, 2014, 146 (05) : S261 - S261
  • [6] Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C
    Kondo, C.
    Atsukawa, M.
    Tsubota, A.
    Shimada, N.
    Abe, H.
    Aizawa, Y.
    JOURNAL OF POSTGRADUATE MEDICINE, 2016, 62 (01) : 20 - 25
  • [7] Effect of telaprevir-based triple therapy on the renal function of chronic hepatitis C patients
    Ozeki, Itaru
    Nakzima, Tomoaki
    Hige, Shuhei
    Karino, Yoshiyasu
    HEPATOLOGY, 2012, 56 : 1040A - 1040A
  • [8] The Effect of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients on Gastric Emptying
    Arai, Makoto
    Oyamada, Arata
    Maruoka, Daisuke
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Kanda, Tastuo
    Katsuno, Tatsuro
    Imazeki, Fumio
    Yokosuka, Osamu
    GASTROENTEROLOGY, 2014, 146 (05) : S615 - S616
  • [9] Safety and Efficacy of Partial Splenic Embolization in Telaprevir-based Triple Therapy for Chronic Hepatitis C
    Kondo, Chisa
    Atsukawa, Masanori
    Tsubota, Akihito
    Shimada, Noritomo
    Abe, Hiroshi
    Itokawa, Norio
    Nakagawa, Ai
    Fukuda, Takeshi
    Matsushita, Yoko
    Nakatsuka, Katsuhisa
    Kawamoto, Chiaki
    Iwakiri, Katsuhiko
    Aizawa, Yoshio
    Sakamoto, Choitsu
    INTERNAL MEDICINE, 2015, 54 (02) : 119 - 126
  • [10] Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy
    Deneke, M. G.
    Dranoff, J. A.
    Duarte-Rojo, A.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2014, 79 (01): : 64 - 66